Clarifying Misinformation on Tamiflu Supply and IPS Practices
On October 23rd, members of the CIPA, IPABC, and MIPA met with members of Health Canada in Ottawa to discuss the implementation of legislation and regulations that will affect the future of IPS practice.
Media Misrepresents Role of IPS in Tamiflu "Shortage"
This meeting corresponded with the recent media focus on the supply and distribution of Tamiflu. Currently, newspapers, television, and radio are incorrectly blaming current IPS practices for the alleged shortage of the Tamiflu antiviral medication. Despite the fact that the Canadian government clearly states that a sufficient supply of Tamiflu for Canadians is already stockpiled, the CPHA, OPA, and other organizations are using the media attention surrounding Tamiflu as a platform against the export of pharmaceuticals from Canada.
DoctorSolve™ Prioritizes Canadians with "Canadians First" Policy
In spite of the Canadian government's assertion that there is no shortage of Tamiflu for Canadians, DoctorSolve™ will no longer offer Tamiflu on our Website. This show of good faith is the only way to demonstrate our commitment to a "Canadians First" policy. In the future, DoctorSolve™ may resume selling Tamiflu. Please check www.doctorsolve.com periodically for updates regarding the availability of Tamiflu.